Galmed Pharmaceuticals Ltd. GLMD

$ 2.79 -0.54%

Annual report 2023
added 11-23-2024

Galmed Pharmaceuticals Ltd. Cash and Cash Equivalents 2011-2024 | GLMD

Annual Cash and Cash Equivalents Galmed Pharmaceuticals Ltd.

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	6.95 M	15.9 M	24.2 M	13 M	3.1 M	4.16 M	23.7 M	137 K	718 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
24.2 M	137 K	10.2 M

Quarterly Cash and Cash Equivalents Galmed Pharmaceuticals Ltd.

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	2.88 M	-	7.92 M	-	6.95 M	-	5.55 M	-	15.9 M	-	25.8 M	-	24.2 M	-	6.15 M	-	13 M	-	1.75 M	-	3.1 M	-	2.95 M	-	4.16 M	-	7.32 M	-	23.7 M	-	-	-	137 K	-	-	-	718 K	-	-	-	146 K	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
25.8 M	137 K	8.46 M